Jefferies Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-27,236
Closed -$19M 1233
2022
Q1
$19M Buy
27,236
+19,197
+239% +$13.4M 0.12% 38
2021
Q4
$5.08M Sell
8,039
-161
-2% -$102K 0.03% 203
2021
Q3
$4.96M Sell
8,200
-9,404
-53% -$5.69M 0.04% 215
2021
Q2
$9.83M Buy
17,604
+7,056
+67% +$3.94M 0.06% 150
2021
Q1
$4.99M Sell
10,548
-6,308
-37% -$2.98M 0.04% 200
2020
Q4
$8.14M Buy
16,856
+7,183
+74% +$3.47M 0.06% 136
2020
Q3
$5.42M Buy
9,673
+2,886
+43% +$1.62M 0.06% 131
2020
Q2
$4.23K Buy
6,787
+6,740
+14,340% +$4.2K 0.05% 159
2020
Q1
$23K Buy
47
+15
+47% +$7.34K ﹤0.01% 1042
2019
Q4
$12K Sell
32
-4,693
-99% -$1.76M ﹤0.01% 1551
2019
Q3
$1.31M Sell
4,725
-1,293
-21% -$359K 0.01% 692
2019
Q2
$1.88M Buy
+6,018
New +$1.88M 0.01% 463
2018
Q4
Sell
-552
Closed -$223K 1651
2018
Q3
$223K Sell
552
-2,850
-84% -$1.15M ﹤0.01% 1332
2018
Q2
$1.17M Buy
3,402
+1,816
+115% +$627K 0.01% 627
2018
Q1
$546K Sell
1,586
-4,870
-75% -$1.68M ﹤0.01% 865
2017
Q4
$2.43M Buy
6,456
+6,357
+6,421% +$2.39M 0.01% 450
2017
Q3
$44K Sell
99
-7,699
-99% -$3.42M ﹤0.01% 1464
2017
Q2
$3.83M Buy
7,798
+6,570
+535% +$3.23M 0.03% 293
2017
Q1
$476K Buy
1,228
+876
+249% +$340K ﹤0.01% 928
2016
Q4
$129K Buy
352
+112
+47% +$41K ﹤0.01% 1159
2016
Q3
$96K Sell
240
-1,980
-89% -$792K ﹤0.01% 1150
2016
Q2
$775K Sell
2,220
-4,865
-69% -$1.7M ﹤0.01% 538
2016
Q1
$2.55M Buy
7,085
+2,635
+59% +$950K 0.01% 250
2015
Q4
$2.42M Buy
+4,450
New +$2.42M 0.01% 270
2015
Q3
Sell
-50
Closed -$26K 1870
2015
Q2
$26K Sell
50
-614
-92% -$319K ﹤0.01% 1686
2015
Q1
$300K Buy
+664
New +$300K ﹤0.01% 958
2014
Q4
Sell
-646
Closed -$233K 1457
2014
Q3
$233K Sell
646
-4,255
-87% -$1.53M ﹤0.01% 1091
2014
Q2
$1.38M Buy
+4,901
New +$1.38M 0.01% 371
2014
Q1
Sell
-3,920
Closed -$1.08M 1488
2013
Q4
$1.08M Buy
3,920
+2,761
+238% +$760K 0.01% 339
2013
Q3
$363K Sell
1,159
-19,756
-94% -$6.19M ﹤0.01% 742
2013
Q2
$4.7M Buy
+20,915
New +$4.7M 0.05% 76